12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersOntrak (NASDAQ:OTRK) stock increased by 44.3% to $0.83 during Wednesday's pre-market session. The market value of their outstanding shares is at $22.4 million. TC BioPharm (Holdings) (NASDAQ:TC
Why Broadwind Shares Are Trading Higher By 85%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Broadwind Inc (NASDAQ:BWEN) shares climbed 85.4% to $4.19 after the company announced the receipt of approximately $175 million in new tower orders from a leading global wind turbine manufactu
ATHX, AVCT and TPST Among Mi-day Movers
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersOntrak (NASDAQ:OTRKP) shares moved upwards by 44.1% to $0.92 during Wednesday's regular session. The current volume of 122.0K shares is 789.0% of Ontrak's average full-day volume over the last
Stocks That Hit 52-Week Lows On Thursday
 On Thursday, 116 companies set new 52-week lows. Noteable 52-Week Lows: Kilroy Realty (NYSE:KRC) was the biggest company on a market cap basis to set a new 52-week low.Akerna (NASDAQ:KERN) was the
Stocks That Hit 52-Week Lows On Wednesday
 On Wednesday, 258 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: Amazon.com (NASDAQ:AMZN) was the largest firm on a market cap basis to set a new 52-week low.The smal
Stocks That Hit 52-Week Lows On Tuesday
 Tuesday's session saw 325 companies set new 52-week lows. 52-Week Low Highlights: Apple (NASDAQ:AAPL) was the biggest company in terms of market cap to set a new 52-week low.InMed Pharmaceuticals
Tempest Therapeutics, Inc. (NASDAQ:TPST) Short Interest Up 22.5% in November
Tempest Therapeutics, Inc. (NASDAQ:TPST – Get Rating) was the recipient of a significant increase in short interest in November. As of November 30th, there was short interest totalling 19,600 shares,
Bears Are Losing Control Over Tempest Therapeutics, Inc. (TPST), Here's Why It's a 'Buy' Now
Tempest to Present at the Piper Sandler 34th Annual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company focused on developing first-in-class therapeutics that com
Loading...
No Stock Yet